SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $5,000 | -16.7% | 30 | -45.5% | 0.00% | -20.0% |
| Q4 2014 | $6,000 | -99.8% | 55 | -99.7% | 0.01% | -99.8% |
| Q3 2014 | $2,615,000 | +7.9% | 16,736 | -14.8% | 2.16% | +10.6% |
| Q2 2014 | $2,423,000 | +60475.0% | 19,646 | +54472.2% | 1.95% | +64833.3% |
| Q1 2014 | $4,000 | 0.0% | 36 | -26.5% | 0.00% | 0.0% |
| Q4 2013 | $4,000 | +33.3% | 49 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $3,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
| Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
| FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
| Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
| FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
| HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
| Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
| ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
| Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |